2024

1. 3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial

   The Lancet, Vol. 403, Núm. 10437, pp. 1649-1659

2. A biologically oriented preparation technique (BOPT) for immediate posterior implant placement, immediate provisionalization, and definitive implant crown fabrication: A complete digital workflow

   Journal of Esthetic and Restorative Dentistry, Vol. 36, Núm. 2, pp. 270-277

3. A case study on pharmaceutical residues and antimicrobial resistance genes in Costa Rican rivers: A possible route of contamination for feline and other species

   Environmental Research, Vol. 242

4. Actions to Avoid in Pain Management and Sedoanalgesia Procedures in Pediatric Emergencies

   Pediatric Emergency Care, Vol. 40, Núm. 4, pp. E23-E29

5. Clinicopathological and molecular predictors of [18F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial

   European Journal of Nuclear Medicine and Molecular Imaging, Vol. 51, Núm. 9, pp. 2733-2743

6. Combinational Diuretics in Heart Failure

   Current Heart Failure Reports, Vol. 21, Núm. 4, pp. 1-11

7. Confirmatory study of the usefulness of quantum molecular resonance and microdissectomy for the treatment of lumbar radiculopathy in a prospective cohort at 6 months follow-up

   Scandinavian Journal of Pain, Vol. 24, Núm. 1

8. Correction: SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022) (Clinical and Translational Oncology, (2023), 25, 9, (2647-2664), 10.1007/s12094-023-03215-4)

   Clinical and Translational Oncology

9. Do birds select the plastics debris used for nest construction? A case study in a Mediterranean agricultural landscape

   Environmental Research, Vol. 255

10. Effect of Reliable Recovery on Health Care Costs and Productivity Losses in Emotional Disorders

    Behavior Therapy, Vol. 55, Núm. 3, pp. 585-594

11. Elevated Troponins after COVID-19 Hospitalization and Long-Term COVID-19 Symptoms: Incidence, Prognosis, and Clinical Outcomes—Results from a Multi-Center International Prospective Registry (HOPE-2)

    Journal of Clinical Medicine, Vol. 13, Núm. 9

12. Four-year Epidemiological Surveillance of the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy: Current Situation and Trends

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 4, pp. 331-340

13. Health equity, mental health, and partnerships to build back after COVID-19: Multistakeholder perspectives at a United Nations event

    Resilient Health: Leveraging Technology and Social Innovations to Transform Healthcare for COVID-19 Recovery and Beyond (Elsevier), pp. 115-146

14. Influence of CAD/CAM Manufacturing Technique and Implant Abutment Angulation on Loosening of Individual Screw-Retained Implant Crowns

    Metals, Vol. 14, Núm. 7

15. Influence of scanning pattern on accuracy, time, and number of photograms of complete-arch implant scans: A clinical study

    Journal of Dentistry, Vol. 150

16. Influence of the medical treatment schedule in new diagnoses patients with heart failure and reduced ejection fraction

    Clinical Research in Cardiology, Vol. 113, Núm. 8, pp. 1171-1182

17. Long-term depressive symptom trajectories and related baseline characteristics in primary care patients: Analysis of the PsicAP clinical trial

    European Psychiatry, Vol. 67, Núm. 1

18. Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study (REGESMOHS, Spanish registry of Mohs surgery)

    Journal of the European Academy of Dermatology and Venereology

19. Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP

    Clinical and Translational Oncology, Vol. 26, Núm. 7, pp. 1647-1663

20. Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy

    Frontiers in Oncology, Vol. 14